APA

Pohl K., Nichols D. P., Taylor-Cousar J. L., Saavedra M. T., Strand M. J., Nick J. A. & Bratcher P. E. (20190514). Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation. : PloS one.

Chicago

Pohl Kerstin, Nichols David P, Taylor-Cousar Jennifer L, Saavedra Milene T, Strand Matthew J, Nick Jerry A and Bratcher Preston E. 20190514. Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation. : PloS one.

Harvard

Pohl K., Nichols D. P., Taylor-Cousar J. L., Saavedra M. T., Strand M. J., Nick J. A. and Bratcher P. E. (20190514). Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation. : PloS one.

MLA

Pohl Kerstin, Nichols David P, Taylor-Cousar Jennifer L, Saavedra Milene T, Strand Matthew J, Nick Jerry A and Bratcher Preston E. Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation. : PloS one. 20190514.